Frontier Medicines

'Tough but necessary decision': Frontier Meds lays off staff

Frontier is streamlining operations “for greater efficiency, focusing resources where they will have the greatest impact,” a spokesperson told Fierce.

Gabrielle Masson Feb 5, 2025 10:52am

An artists illustration of a KRAS G12C mutation in non-small cell lung cancer

AACR: KRAS inhibitors pop in preclinical data debuts

Apr 11, 2024 4:30am

Palm tree branches bending as storm clouds approach

Frontier CEO weathers one of his hardest fundraises to add $80M

Feb 22, 2024 4:01pm

race runners running sprint marathon catch up

Next round of KRAS drugs follow footsteps of Amgen and Mirati

May 4, 2023 6:00am

Billy Dunn departs FDA—Chutes & Ladders

Mar 3, 2023 9:30am

AbbVie pays Frontier $55M to pursue hard-to-drug targets

Dec 3, 2020 8:05am